The first step in branched-chain amino acid biosynthesis is catalyzed by acetohydroxyacid synthase (EC 2.2.1.6). This reaction involves decarboxylation of pyruvate followed by condensation with either an additional pyruvate molecule or with 2-oxobutyrate. The enzyme requires three cofactors, thiamine diphosphate (ThDP), a divalent ion, and flavin adenine dinucleotide (FAD). Escherichia coli contains three active isoenzymes, and acetohydroxyacid synthase I (AHAS I) large subunit is encoded by the ilvB gene. In this study, the ilvB gene from E. coli K-12 was cloned into expression vector pETDuet-1, and was expressed in E. coli BL21 (DH3). The purified protein was identified on a 12% SDS-PAGE gel as a single band with a mass of 65 kDa. The optimum temperature, buffer, and pH for E. coli K-12 AHAS I were 37 C, potassium phosphate buffer, and 7.5. Km values for E. coli K-12 AHAS I binding to pyruvate, Mg þ2 , ThDP, and FAD were 4.15, 1.26, 0.2 mM, and 0.61 M respectively. Inhibition of purified AHAS I protein was determined with herbicides and new compounds.
Acetohydroxyacid synthase (AHAS, EC 2.2.1.6; also known as acetolactate synthase) is a thiamine diphosphate (ThDP) dependent enzyme that catalyzes the first step in the biosynthesis of branched-chain amino acids. The reaction involves an irreversible decarboxylation of pyruvate to a bound hydroxyethyl group that then condenses with a second pyruvate molecule to form 2-acetolacte or with 2-ketobutyrate to form 2-aceto-2-hydroxybutyrate.
1) The former product is the precursor for valine and leucine biosynthesis, while the latter leads to isoleucine. In addition, 2-caetolactate is the precursor for AHAS conversion into diacetyl, which is responsible for off-flavoring in beer.
2) AHAS requires three cofactors for activity: ThDP, flavin adenine dinucleotide (FAD), and Mg þ2 or Mn þ2 ion. 3, 4) AHAS is the site of action of sulfonylurea, imidazolinone, triazolopyrimidine, and pyrimidylbenzoate herbicides, [5] [6] [7] [8] which might operate by binding to the regulatory site on the enzyme. 7) AHAS activity is found in bacteria, fungi, and plants, and is contributed by one or more isozymes. Enterobacterial isozymes are known to be composed of large (approximately 60 kDa) and small (approximately 9-17 kDa) subunits in equimolar amounts. [9] [10] [11] E. coli causes intra-and extra-intestinal infections causing diarrhea, urinary tract infections, meningitis, peritonitis, mastitis, and septicemia. 12) To develop potential microbial AHAS drug targets, we cloned, expressed, purified, and characterized the catalytic subunit of AHAS I from E. coli K-12 and identified E. coli K-12 AHAS I inhibitors by herbicide screening.
Materials and Methods
Materials. E. coli K-12 was purchased from the Korea Institute of Science and Technology (Seoul, Korea). Herbicides were from the Korea Research Institute of Chemical Technology (Deajeon, Korea). Bacto Trypton, yeast, and Bacto Agar were purchased from Difco Laboratories (Sparks, NV). Restriction enzymes, Pfu DNA polymerase, and T4 DNA ligase were from Promega (Madison, WI). Sodium pyruvate, FAD, ThDP, MgCl 2 , IPTG (isopropyl--D-thiogalactoside), creatine, and -naphthol were from Sigma Chemical (St. Louis, MO). All other chemicals were used from commercial sources and were of the highest quality available.
Cloning of E. coli K-12 AHAS I gene. E. coli K-12 was grown in Luria-Bertani broth at 37 C. Total genomic DNA from E. coli K-12 was isolated, and 300 ng was used as template for the polymerase chain reaction (PCR). PCR amplification of the AHAS I gene was conducted with the following primers: 5 0 -GGATCCATGGCAAGTTCGGGC-ACAAC-3 0 and 3 0 -GCGGCCGCTTATTCCCCCACCATTTCAGT-5 0 . Underlined nucleotide sequences represent BamHI and NotI restriction sites respectively. The PCR reaction was performed with the following parameters: 95 C, 10 min; 30 cycles of 95 C, 2 min; 53 C, 2 min; 72 C, 2 min; and 72 C, 10 min. The PCR product was purified using a gel extraction kit (MP Biomedicals). The 1.7 kb PCR fragment was identified as the ilv B gene by restriction enzyme mapping analysis. The fragment was cloned into pETDuet-1 expression vector, using the BamHI and NotI restriction sites by ligation with T4 DNA ligase. The product, pETDuet-1-AHAS, was used to transform E. coli BL21 (DH3), and transformants were selected on Luria-Bertani plates containing 100 mg/ml of ampicillin. Colonies were selected and screened to isolate plasmid DNA containing the gene encoding for the AHAS protein. The plasmid construct was further identified by restriction enzyme mapping and DNA sequencing.
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Expression of E. coli K-12-AHAS I. The E. coli BL21 (DH3) expression host was transformed with pETDuet-1-AHAS I, which has relatively low protease activity. A single transformant was grown in subculture at 37 C overnight, and was subsequently used to inoculate a 1.0 liter Luria-Bertani culture containing 100 mg/ml of ampicillin. The culture was incubated with shaking until an OD 600 of 0.7-0.8 was reached, and overexpression of the target protein was induced by the addition of 1 mM of IPTG with subsequent incubation at 18 C overnight. Cell pellets were harvested by centrifugation at 10,000 rpm for 15 min at 4 C. The cell pellets was washed once with PBS and stored at À80 C until use.
Purification of E. coli K-12-AHAS I protein. Cell pellets were resuspended in 50 ml of buffer containing 20 mM sodium phosphate, pH 8.0, 0.5 M NaCl, 20 mM phenylmethanessulfonyl fluoride (PMSF), 0.5 mg/ml of lysozyme, and 0.5% Triton X-100. The reaction was incubated at room temperature for 30-40 min, kept on ice for 20 min, and lysed via ultrasonication on ice. Cell debris was removed by centrifugation at 14,000 rpm for 30 min, and the clear supernatant was filtered using a 0.45 mm syringe filter. The filtrate was directly loaded, at a flow rate of 0.5 ml/min at 4 C, onto a Ni þ2 -charge Hi Trap chelating column that was equilibrated with 20 mM sodium phosphate, pH 8.0, 0.5 M NaCl, 20 mM imidazole, and the bound protein was eluted by applying a linear gradient of imidazole (20-500 mM) at a flow rate 1 ml/min with a total of 60 ml. Fractions containing the expressed protein were dialyzed of against 20 mM Tris-HCl, pH 8.0, containing 5 mM EDTA, and 5 mM -mecaptoethanol. The fraction was concentrated protein using an Amicon stirrer, and stored at À80 C until use. Protein concentration were determined by the Bradford method, 13) with modifications to the protocol supplied by the manufacturer (BioRad, Boston, MA).
Enzyme assay. The activity and specificity of AHAS I were measured by the Singh method with the following modifications: 14) The assay solution contained a final concentration of 100 mM potassium phosphate, pH 7.6, 1 mM ThDP, 10 mM MgCl 2 , and 50 mM FAD in the presence and the absence of various cofactors, and inhibitor concentrations. The mixture reaction was pre-incubated at 37 C for 10 min, and the reaction was initiated by the addition of 0.5 mg purified AHAS I in a total volume of 200 ml. After incubation for 1 h, the enzyme reaction was terminated by the addition of 30 ml H 2 SO 4 . The reaction product, acetolactate, was formed by decarboxylation at 65 C for 15 min. Then 100 ml of the reaction product was mixed with 90 ml of 0.5% creatin (w/v) and 90 ml of 5% (w/v) -naphthol dissolved in 2.5 M NaOH. After incubation at 65 C for 15 min, acetoin was formed by acidification. Color development was measured by the absorbance at 525 nm. Since acetolactate is chemically unstable, acetoin was used as the standard to determine the absorption coefficient (20,000M-1 cm-1) for the color complex. One unit of enzyme activity was defined as that producing 1 mmol of acetolactate/min under the above conditions. Specific activity was expressed as enzyme units/mg of catalytic subunit as determined by bicinchoninic acid protein assay, unless otherwise stated.
Determination of optimum buffer, pH, and temperature. Partially purified E. coli K-12 AHAS I was assayed over a range of pH values using three different buffer systems of: MES(2-(N-morpholino)ethanessulfonic acid) at pH 5-6; HEPES (N-(2-hydroxylethyl)piperazine-N-(2-ethanesulfonic acid) at pH 6-8; and CHES (2-(N-cyclohexylamino)ethanesulfonic acid) at pH 8-10. All the buffers were titrated to the appropriate pH levels using NaOH. pH was maintained using buffers at 100 mM, and determination of optimum pH was repeated several times using different preparations. Optimum temperature was determined over a C range. For pH and temperature dependence, AHAS I activity was conducted as described above. Samples were incubated at 37 C for 30 min.
SDS-PAGE. SDS-PAGE was done by the Laemmli method. 15) Protein were separated on a 12% polyacrylamide gel using a Bio-Rad power supply (model 1000/500), and was detected by staining with 0.1% Coomassie Blue.
Determination of kinetic parameters. All experimental data were analyzed using programs based on Origin Pro 6.1. The V max and Km for the substrate and cofactors were determined by fitting the data into eq. (1)
where v is the reaction velocity, V max is the maximum velocity, [S] is the substrate concentration, and Km is the Michaelis-Menten constant. The 50% inhibition concentration (IC 50 ) was analyzed by fitting to eq. (2)
where V 0 is the reaction rate without inhibitor, V f is the rate at maximal inhibition, and [I] is the inhibitor concentration.
Results

Expression and purification of AHAS I
The gene encoding the catalytic subunit of AHAS I from E. coli K-12 was obtained by PCR amplification (of 1.7 kb fragment). The recombinant catalytic subunit from E. coli K-12 was expressed in E. coli BL21 (DH3) as an N-terminal 6xHis tag fusion protein at 18 C to increase protein solubility.
The E. coli K-12 AHAS I protein was purified using immobilized-metal affinity chromatography. As expected, most of the AHAS I enzyme was bound to the resin, and unbound protein was removed by washing with 20 mM imidazole. A gradient of 20-500 mM imidazole was used to elute the purified protein, which was subjected to SDS-PAGE analysis (Fig. 1) . The molecular mass of the enzyme was estimated to be 65 kDa.
Optimum buffer, temperature, and pH for AHAS I activity Determination of the optimum pH was repeated several times using seven different buffer systems. The optimum pH for E. coli K-12 AHAS I was 7.6 ( Fig. 2A) , with an optimum temperature of 37 C (Fig. 2B) . Partially purified E. coli K-12AHAS I protein activity was assayed with a range of buffers. As shown in Fig. 2C , potassium phosphate buffer was the best buffer for enzymatic activity. Biochemical characterization of E. coli K-12 AHAS The kinetic properties of E. coli K-12 AHAS I were determined by a discontinuous assay as described in ''materials and method.'' The Km for values for pyruvate, Mg þ2 , ThDP, and FAD were 4.15, 1.26, 0.2 mM, and 0.61 mM respectively. Figure 3 depicts the saturation curves for E. coli K-12 AHAS I with pyruvate, Mg þ2 , ThDP, and FAD. A comparison of the biochemical properties of E. coli K-12 AHAS I with that of other purified AHASs is reported in Table 1 . The specific activity of the catalytic subunit was 1.5 U/mg.
Inhibition of AHAS I by herbicides
Sulfonylureas (SU), imidaziliones (IM), and triazolopyrimidines (TP) are known to inhibit the AHAS enzyme from bacteria, yeast, and plant efficiently. [5] [6] [7] [8] In this study, we examined the inhibition of E. coli K-12 AHAS I using several herbicides, including the sulfonylurea derivatives chlorimuron ethyl (CE), chlorsulfuron (CS), metsulfuron methyl (MSM), sulfometuron methyl (SMM), pirimisulfuron (PSM), nicosulfuron (NS), bensulfuron methyl (BSM), and pyrazosulfuron ethyl (PSE), along with thifensulfuron methyl (TSM) and the imidazolinone derivatives imazapyr, imazethapyr, imazapic, and imazaquin. The structures of these herbicides have been published.
16) The majority of the sulfonylurea and imidazolione derivatives did not inhibit E. coli K-12 AHAS I activity at a concentration of 100 mM (data not shown). However, in our study 4-(2-(fluoromethyl)-1,3 dioxolan-2-yl)-N-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoyl) thiophene-3sunfonamide (sulfonylurea group) and (E)-8-fluoro-N-(2-fluoro-6-(1-(methoxyimino)ethyl)phenyl)-5-methoxy-(1,2,4)triazolo(1,5-f)pyrimidine-2sulfonamide (triazolopyrimidine herbicide group) were moderate inhibitors. The percent inhibition values for the E. coli K-12 AHAS I catalytic subunit were 67 and 84%, respectively, with of IC 50 values were calculated at 42.6 and 33.7 mM respectively (Fig. 4) .
In previous studies, we identified a new inhibitor of Mycobacterium tuberculosis 16) by screening a chemical library. Here, we investigated the ability of these hit compounds to inhibit E. coli K-12 AHAS I. Indeed, compound KHG20612, which has a triazole ring containing a substitution of 3-phenyldisfulfanyl and 1-phenylamide, inhibited E. coli K-12 AHAS I. Another compound that we identified, KSW30191, which contains a ubiquinone-O moiety known to inhibit Haemophilus influenzae 17) also inhibited E. coli K-12 AHAS I activity. KHG20162 and KSW360191 were strong inhibitors, with IC 50 values of 3.4 and 4.5 mM respectively, and showed a 7.5 to 12.5 fold stronger than inhibition to 4-(2-(fluoromethyl)-1,3 dioxolan-2-yl)-N-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoyl) thiophene-3sunfonamide (sulfonylurea group) and (E)-8-fluoro-N-(2-fluoro-6-(1-(methoxyimino)ethyl)phenyl)-5-methoxy-(1,2,4)triazolo(1,5-f)pyrimidine-2sulfonamide (triazolopyrimidine herbicide group).
A chemical library obtained from the Korea Chemical Bank was screened for E. coli K-12 AHAS I. We found that AVS2087, AVS2093, AVS2236, and AVS2397 (Fig. 5) were strong inhibitors, with IC 50 values of 22.2, 21.2, 30.1, and 32.5 mM, respectively (Fig. 4) . The main scaffold of these compounds consisted of a 1,2,4-triazole-3sulfoamide with various replaced groups: AVS2087, with 1-(4,6-dimethoxy-2-pyrimidinyl), 5-methyl, and N-(2-isopropyl-6-nitrophenyl) replaced groups; AVS2093, with 1-(4,6-dimethoxy-2-pyrimidinyl), 5-methoxymethyl, and N-(2-isopropyl-6-nitrophenyl) replaced groups; AVS2236, with 1-(4-chloro-6-methoxy-2-pyrimidinyl),5-methoxy, and N-(2-methyl-6-nitrophenyl) replaced groups; and AVS2397, with 1-(4,6-dimethoxy-2-pyrimidinyl),5-methylthio, and N-(2shloro-6-fluorophenyl) replaced groups.
Discussion
AHAS activity is required in E. coli K-12 and other enteric bacteria for the biosynthesis of -aceto--hydroxybutyrate and -acetolactate for isoleucine and valine biosynthesis. AHAS I is an essential enzyme for isoleucine and valine biosynthesis when E. coli K-12 is grown on acetate or oletate as sole carbon source. 18) There are reports on the purification, subunit composition, 10) and role of the AHAS I small subunit from E. coli K-12 in sensitivity of the enzyme to valine inhibition. 19) Recently, it was found that a branchedchain amino acid auxotrophic strain of Mycobacterium failed to proliferate due to an inability to use amino acids from the host. 20) These observations suggest that AHAS is a potential target of new antibacterial drugs. 21) Here, we describe the heterogonous expression, purification, and characterization of E. coli K-12 AHAS I. Purification of AHAS for biochemical characterization required subcloning of the gene into the pETDuet-1 expression vector. Purification of the protein resulted in e Date taken from 23) more than 95% purity. The inferred molecular mass of the catalytic subunit encoded by the ilv B gene was confirmed to be 65 kDa on SDS-PAGE. Like related enzymes that catalyze the decarboxylation of pyruvate, the AHAS I enzyme requires three cofactors, ThDP, FAD, and a divalent metal ion Mg þ2 , for its activity. The kinetic parameters for the interaction of the enzyme with the substrate and cofactors were determined, and were compared with those of other purified AHASs. E. coli K-12 AHAS I specific activity was 1.5 U/mg, similar to 2.8 U/mg for the AHAS from M. tuberculosis, 16) 1.5 U/mg for H. influenza, 17) and 1.5 U/mg for Bacillus anthracis. 22) However, its activity was several-fold lower than that of Arabidopsis thaliana (7.88 U/mg) 23) and Nicotiana tabacum (2.8-8.1 U/mg). 24) It is important to determine enzyme stability relative to the buffer, temperature, and the pH range studied. The E. coli K-12 AHAS I had very low activity at low and high temperatures respectively. The optimum temperature and pH value for E. coli K-12 AHAS I activity were 37 C and 7.6, consistent with values obtained for B. anthracis, 22) H. influenza, 17) and of permeabilized yeast cell (pH [7] [8] 25) AHAS enzyme. In this study, E. coli K-12 AHAS I inhibition by herbicides from three different classes known to inhibit other AHASs was examined. The imidazolinone family of herbicides consist of a 4-isopropyl-4-metyl-5-oxo-2-imidazolin-2-yl nucleus linked at the 2-position to an aromatic ring system. They are useful herbicides but far less efficient inhibitors. 26) Imidazolinone did not inhibit E. coli K-12 AHAS I in significant way at the concentration tested (data not shown), as compared to AHAS enzymes from A. thaliana 23) and S. cerevisiae.
27) The basic structure of the sulfonylurea herbicides is X-SO 2 -NH-CO-Y, where X is usually a substituted to phenyl group and Y is a substituted to pyrimidine or triazine ring that has biological activity. Typically, herbicides from this group are stronger inhibitors than those of the imidazolione herbicide group, but in this study, most of the compounds that belonged to the sulfonylurea herbicide group were weak inhibitors, if any activity was detected at all. These results are in accord with those for the inhibition of the H. influenza AHAS, 17) but the sulfonylurea herbicides were strong inhibitors of B. anthracis 22) and M. tuberculosis. 16) We found that 4-(2-(fluoromethyl)-1,3 dioxolan-2-yl)-N-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoyl) thiophene-3sunfona-mide (sulfonylurea group) and (E)-8-fluoro-N-(2-fluoro-6-(1-(methoxyimino)ethyl)phenyl)-5-methoxy-(1,2,4)triazolo(1,5-f)pyrimidine-2sulfonamide (triazolopyrimidine herbicide group) were weak inhibitors of the E. coli K-12 AHAS I catalytic subunit. These results indicate that the E. coli K-12 AHAS I active site is probably different from previously characterized AHAS enzymes from plants and yeasts.
We identified new inhibitors via chemical library screening that showed several-fold inhibition. One such new compound, KSW30191, has a quinone moiety. Pyruvate oxidase which belongs to the family of ThDP dependent enzymes, requires ubiquinone-O as a cofactor in vivo. Thus, the structural similarity of KSW30191 to ubiquinone and the inhibition property of this compound against E. coli K-12 AHAS I suggests that the binding site of this quinone moiety is highly conserve and shares a common evolutionary heritage with the pyruvate oxidase enzyme.
The triazolopyrimidines are a major herbicide group that targets AHAS enzymes. The triazolopyrimidines consist of a di-or tri-substituted aromatic ring linked by a short bridge to a replaced triazolopyrimidin ring system. In the aromatic ring, an electron-withdrawing group, such as NO 2 is typically replaced in the aromatic ring at the orthor-position. The structure of the new inhibitors identified in this study, AVS2087, AVS2093, AVS2236, AVS2397, are similar to triazolopyrimidines, which have a 2-isopropyl-6-nitroohenyl group. These were more potent inhibitors than the sulfonylureas or imidazoliones.
In this study, we amplified the ilv B gene by extension PCR, cloned the 1.7 kb fragment into an expression vector. The DNA sequence was confirmed (data not shown) and the E. coli K-12 AHAS I protein was expressed and purified. We report a biochemical characterization of the E. coli K-12 AHAS I protein at optimum temperature, buffer, and pH, and we determined the parameters for the interaction of the enzyme with substrate and cofactors. Lastly, we tested inhibition of the enzyme with herbicide groups and new compounds, and several compounds were found to be strong inhibitors of the E. coli K-12 AHAS I enzyme. In the near future, we plan to study further the mechanism of AHAS inhibition by these inhibitors along with their effects on E. coli K-12 growth. We hope that these approaches will contribute to the future development of new antibacterial drugs that target the AHAS enzyme. 
